Inventor · disambiguated record
Tongmei Li
Also filed as: LI TONGMEI
26 granted patents·6 pending applications·348 citations·filing 2001–2017
95Inventor score
Top patents by PatentIndex Score
32 records- 0197US6831175B2Kinase inhibitorsABBOTT LAB·Filed 2002·Granted Dec 14, 2004·214 cites·21 claims
- 0293US7875639B2Compounds as cannabinoid receptor ligands and uses thereofABBOTT LAB·Filed 2007·Granted Jan 25, 2011·26 cites·14 claims
- 0393US7872033B2Compounds as cannabinoid receptor ligandsABBOTT LAB·Filed 2008·Granted Jan 18, 2011·26 cites·24 claims
- 0491US8501794B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2009·Granted Aug 6, 2013·17 cites·7 claims
- 0590US8492371B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2010·Granted Jul 23, 2013·18 cites·17 claims
- 0690US8158663B2Compounds as cannabinoid receptor ligands and uses thereofCARROLL WILLIAM A·Filed 2007·Granted Apr 17, 2012·17 cites·7 claims
- 0785US7704997B1Amino-tetrazole analogues and methods of useABBOTT LAB·Filed 2005·Granted Apr 27, 2010·7 cites·13 claims
- 0884US8217067B2Amino-tetrazoles analogues and methods of useCARROLL WILLIAM A·Filed 2005·Granted Jul 10, 2012·6 cites·13 claims
- 0983US7723367B2Amino-tetrazoles analogues and methods of useABBOTT LAB·Filed 2008·Granted May 25, 2010·5 cites·4 claims
- 1079US7323570B2Farnesyltransferase inhibitorsABBOTT LAB·Filed 2006·Granted Jan 29, 2008·2 cites·5 claims
- 1173US7211595B2Farnesyltransferase inhibitorsABBOTT LAB·Filed 2001·Granted May 1, 2007·5 cites·34 claims
- 1272US9676797B2Anti-viral compoundsABBVIE INC·Filed 2016·Granted Jun 13, 2017·1 cites·15 claims
- 1369US8895592B2Compounds as cannabinoid receptor ligandsFROST JENNIFER M·Filed 2009·Granted Nov 25, 2014·2 cites·12 claims
- 1463US7056925B2Urea kinase inhibitorsABBOTT LAB·Filed 2003·Granted Jun 6, 2006·2 cites·20 claims
- 1561US8859596B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2009·Granted Oct 14, 2014·0 cites·9 claims
- 1661US8188135B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2009·Granted May 29, 2012·0 cites·16 claims
- 1756US10053474B2Anti-viral compoundsABBVIE INC·Filed 2017·Granted Aug 21, 2018·0 cites·17 claims
- 1854US8546374B2Amino-tetrazoles analogues and methods of useCARROLL WILLIAM A·Filed 2012·Granted Oct 1, 2013·0 cites·24 claims
- 1953US8846730B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2009·Granted Sep 30, 2014·0 cites·22 claims
- 2052US8841334B2Compounds as cannabinoid receptor ligands and uses thereofFLORJANCIC ALAN S·Filed 2008·Granted Sep 23, 2014·0 cites·18 claims
- 2151US9193713B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2008·Granted Nov 24, 2015·0 cites·24 claims
- 2249US9006275B2Compounds as cannabinoid receptor ligands and uses thereofFLORJANCIC ALAN S·Filed 2010·Granted Apr 14, 2015·0 cites·2 claims
- 2346US8835475B2Compounds as cannabinoid receptor ligandsCARROLL WILLIAM A·Filed 2010·Granted Sep 16, 2014·0 cites·2 claims
- 2446US2003187026A1Kinase inhibitorsFiled 2002·Application pending·0 cites
- 2546US2015231141A1Novel compounds as cannabinoid receptor ligands and uses thereofABBVIE INC·Filed 2015·Application pending·0 cites
- 2645US8546583B2Compounds as cannabinoid receptor ligands and uses thereofFLORJANCIC ALAN S·Filed 2007·Granted Oct 1, 2013·0 cites·5 claims
- 2745US2007259920A1P2X7, receptor antagonists and uses thereofCARROLL WILLIAM A·Filed 2006·Application pending·0 cites
- 2842US2004034038A1Urea kinase inhibitorsFiled 2002·Application pending·0 cites
- 2939US2002115640A1Farnesyltransferase inhibitorsFiled 2001·Application pending·0 cites
- 3039US2019358214A1Compositions and Methods for Treating HCV InfectionABBVIE INC·Filed 2017·Application pending·0 cites
- 3138US8859549B2Potassium channel modulatorsBROWN BRIAN S·Filed 2012·Granted Oct 14, 2014·0 cites·22 claims
- 3234US8629143B2Potassium channel modulatorsBROWN BRIAN S·Filed 2010·Granted Jan 14, 2014·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Tongmei Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →